IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
2011.06.28, US 201161502167 P
2012.06.27, WO PCT/US12/044451
A. FUNARO ET AL: "CD157 is an important mediator of neutrophil adhesion and migration", BLOOD, vol. 104, no. 13, 15 December 2004 (2004-12-15), pages 4269-4278, XP055060204, ISSN: 0006-4971, DOI: 10.1182/blood-2004-06-2129 (B1)
WINKLER K ET AL: "Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 165, no. 8, 15 October 2000 (2000-10-15), pages 4505-4514, XP002579393, ISSN: 0022-1767 (B1)
CEDARLANE LABORATORIES LIMITED: "PURIFIED ANTI-MOUSE CD157 RECEPTOR MONOCLONAL ANTIBODY", , 10 October 2008 (2008-10-10), XP002695721, Retrieved from the Internet: URL:https://www.cedarlanelabs.com/Products /Detail/Reagents?code=CL8984AP [retrieved on 2013-04-18] (B1)
E. ORTOLAN ET AL: "Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma", JNCI JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. 102, no. 15, 4 August 2010 (2010-08-04), pages 1160-1177, XP055050187, ISSN: 0027-8874, DOI: 10.1093/jnci/djq256 (B1)
F. MALAVASI ET AL: "Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology", PHYSIOLOGICAL REVIEWS, vol. 88, no. 3, 1 July 2008 (2008-07-01), pages 841-886, XP055060177, ISSN: 0031-9333, DOI: 10.1152/physrev.00035.2007 (B1)
ISHIHARA K ET AL: "BST-1/CD157 regulates the humoral immune responses in vivo.", CHEMICAL IMMUNOLOGY 2000, vol. 75, 2000, pages 235-255, XP9168970, ISSN: 1015-0145 (B1)
JP-A- 2005 295 921 (B1)
KAISHO T ET AL: "Bst-1, a Surface Molecule of Bone Marrow Stromal Cell Lines that Facilitates Pre-B Cell Growth", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 91, 1 June 1994 (1994-06-01), pages 5325-5329, XP002998621, ISSN: 0027-8424, DOI: 10.1073/PNAS.91.12.5325 (B1)
MCNAGNY ET AL: "BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.", THE JOURNAL OF IMMUNOLOGY, vol. 141, no. 8, 1 October 1988 (1988-10-01), pages 2551-2556, XP055060334, ISSN: 0022-1767 (B1)
MIZUE SEKI ET AL: "An Immature Rat Lymphocyte Marker CD157: Striking Differences in the Expression between Mice and Rats", IMMUNOBIOLOGY, vol. 203, no. 5, 1 August 2001 (2001-08-01), pages 725-742, XP055060333, ISSN: 0171-2985, DOI: 10.1016/S0171-2985(01)80002-4 (B1)
N. LO BUONO ET AL: "The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 286, no. 21, 27 May 2011 (2011-05-27) , pages 18681-18691, XP055060178, ISSN: 0021-9258, DOI: 10.1074/jbc.M111.227876 (B1)
NIMMERJAHN ET AL: "Antibodies, Fc receptors and cancer", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 19, no. 2, 8 March 2007 (2007-03-08), pages 239-245, XP005917726, ISSN: 0952-7915, DOI: 10.1016/J.COI.2007.01.005 (B1)
OKUYAMA Y ET AL: "Human BST-1 Expressed on Myeloid Cells Functions as a Receptor Molecule", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 228, no. 3, 21 November 1996 (1996-11-21), pages 838-845, XP002113949, ISSN: 0006-291X, DOI: 10.1006/BBRC.1996.1741 (B1)
RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 79, 1 March 1982 (1982-03-01), pages 1979-1983, XP007901436, ISSN: 0027-8424, DOI: 10.1073/PNAS.79.6.1979 (B1)
SPOSATO P ET AL: "Analysis of human CD157 by murine monoclonal antibodies (MoAbs)", TISSUE ANTIGENS, vol. 55, no. Supplement 1, 2000, page 71, XP9168941, & 7TH WORKSHOP AND CONFERENCE ON HUMAN LEUCOCYTE DIFFERENTIATION ANTIGENS; HARROGATE, ENGLAND, UK; JUNE 20-24, 2000 ISSN: 0001-2815 (B1)
TODD ET AL: "The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen.", BLOOD, vol. 65, no. 4, 1 April 1985 (1985-04-01), pages 964-973, XP055060226, ISSN: 0006-4971 (B1)
CARTER P J: "POTENT ANTIBODY THERAPEUTICS BY DESIGN", THE JOURNAL OF IMMUNOLOGY, NATURE PUB. GROUP, GB, vol. 6, 7 April 2006 (2006-04-07), pages 343-357, XP007901440, ISSN: 1474-1733, DOI: 10.1038/NRI1837 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphørt | Ikke betalt årsavgift |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
Utgående
EP Påminnelse om ikke betalt årsavgift (3331) (PTEP2726508)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 10. avg. år (EP) | 2021.06.29 | 3200 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2020.06.29 | 2850 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2019.06.27 | 2550 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2018.06.28 | 2200 | COMPUTER PACKAGES INC | Betalt og godkjent |
31713808 expand_more expand_less | 2017.09.06 | 5500 | Nordic Patent Service A/S | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|